熱門資訊> 正文
Inventiva SA报告900万个结果
2025-11-22 05:05
- Inventiva S.A (IVA): Revenues for the first nine months of 2025 amounted to €4.5 million, compared to none generated for the same period in 2024.
- Cash and cash equivalents at €97.6 million, and €24.7 million in short-term deposits as of September 30, 2025.
- Cash runway expected until the end of the first quarter of 2027.
More on Inventiva S.A
- Inventiva S.A. (IVA) Analyst/Investor Day - Slideshow
- Inventiva S.A. (IVA) Analyst/Investor Day Transcript
- Inventiva announces $125M U.S. public offering of ADSs
- MASH drug developers rise as FDA accepts lenient trial requirement
- Seeking Alpha’s Quant Rating on Inventiva S.A
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
